The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
For security reasons this page cannot be displayed.
，详情可参考爱思助手下载最新版本
这不是企业家的道德问题，而是理性的风险规避。在产权可能被侵蚀、政策可能逆转的环境中，最理性的选择就是不投资。
More on this storyStop dithering on Brazilian butt lift crackdown, say MPs
arXiv:2602.18602 (cs)